Clinical Trials Browser

Withdrawn × Hyaluronoglucosaminidase × 30 days × Clear all

NCT07082270 2026-05-15

Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma

Phase 1 Withdrawn

Multiple Myeloma